SCHEMBL6923669

SCHEMBL6923669

Oc1cccc2c1c1cc(F)ccc1n2Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.50
CYP19A1 P11511 1/20 0.49
MAPT P10636 3/20 0.48
ALDH1A1 P00352 3/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
KDM4E B2RXH2 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
GAA P10253 1/20 0.47
HK1 P19367 1/20 0.47
HTT P42858 1/20 0.47
HKDC1 Q2TB90 1/20 0.47
PLA2G2A P14555 1/20 0.45
HSD17B10 Q99714 1/20 0.45
HDAC1 Q13547 2/20 0.44
HDAC8 Q9BY41 2/20 0.44
HDAC6 Q9UBN7 2/20 0.44
HDAC11 Q96DB2 1/20 0.44
P2RX4 Q99571 1/20 0.44
POLB P06746 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6921048 0.93 HDAC1 (0.43) SRCMAPTALDH1A1MEN1KMT2A
SCHEMBL7723992 0.86 SRC (0.53) SRCCYP19A1MAPTALDH1A1MEN1
SCHEMBL6924327 0.85 SRC (0.51) SRCCYP19A1MAPTALDH1A1MEN1
SCHEMBL6926577 0.84 MAPT (0.43) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL6921173 0.84 CYP19A1 (0.65) SRCCYP19A1MAPTALDH1A1MEN1
SCHEMBL6923659 0.84 KMT2A (0.51) SRCCYP19A1MAPTALDH1A1MEN1
SCHEMBL6923683 0.83 KDM4E (0.44) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL6920467 0.81 PLA2G2A (0.55) KMT2APLA2G2AP2RX4
Pyridine SCHEMBL7506032 0.78 SRC (0.44) SRCCYP19A1MAPTALDH1A1MEN1
SCHEMBL7505287 0.78 ESR1 (0.44) MAPTMEN1KMT2AKDM4EPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1169789-C Aminoalkoxy carbazoles for the treatment of CNS diseases 法玛西雅厄普约翰美国公司 2004-10-06 CN disclosed
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
CN-1372547-A Aminoalkoxy carbazoles for the treatment of CNS diseases UPJOHN CO (US) 2002-10-02 CN disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed